Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival

European Journal of Surgical Oncology

Volumn 28, Issue 6, 2002, Pages 637-644

  Khan, A ^a   Dhillon, A ^a   Hutchins, R ^b   Abraham, A ^a   Shah, S ^a   Snooks, S ^b   Davidson, B ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

Ampullary cancer pancreaticoduodenectomy; Intratumoral microvessel density; Pancreatic cancer; Tumour Angiogenesis

Indexed keywords

CD34 ANTIGEN; PARAFFIN;

ADULT; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER SURGERY; CANCER SURVIVAL; CAPILLARY DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RANK SUM TEST; SOLID TUMOR; SURVIVAL TIME; TISSUE SECTION; TUMOR VASCULARIZATION; VATER PAPILLA CARCINOMA;

EID: 0036740605     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2002.1307     Document Type: Article

References (25)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 1990 82: 4-6.
2. Weidner N, Semple JP, Welch WR, Folkman J. (editorial). Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
3. Martin L, Holcombe C, Green B, Leinster SJ, Winstanley J. Is a histological section representative of whole tumour vascularity in breast cancer? Br J Cancer 1997; 76: 40-3.
4. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M et al. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 1995; 177: 57-63.
5. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol 1995; 154: 69-71.
6. Ikeda N, Adachi M, Taki T. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999; 79: 1553-63.
7. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB et al. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Europ J Cancer 1998; 34: 337-40.
8. Gebhardt C, Meyer W, Reichel M, Wunsch PH. Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Arch Surg 2000; 385: 14-20.
9. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230: 776-80.
10. Sorensen A, Lundemose JB, Rokkjaer M, Jacobsen NO. Whipple's operation for carcinoma of the pancreatic head and the ampullary region. Short-and long-term results. Scand J Gastroenterol 1998; 33: 759-64.
11. Willett C.G., Lewandrowski K, Warshaw A, Efird K, Compton C. Resection margins in carcinoma head of pancreas. Implications for radiation therapy. Ann Surg 1993; 217: 144-8.
12. Kaplan E, Meier P. Nonparamentric estimation from incomplete observations. J Am Stat Assoc 1958; 58: 457-81.
13. Yeo CJ, Caeron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al. Six hundred and fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997 226: 248-57.
14. Gasparini G. Prognostic and predictive value of intra-tumoral microvessel density in human solid tumours. In: Bicknell R, Lewis CE, Ferrara N (eds). Tumour Angiogenesis. New York: Oxford University Press Inc., 1997: 29-44.
15. Martin L, Green D, Renshaw C, Rudland P, Lowe D, Winstanley J. Examining the technique of angiogenesis assessment in invasive breast cancer. Br J Cancer 1997; 76: 1046-54.
16. Martin L, Holcombe C, Green B, Winstanley J, Leinster SJ. Vascular heterogeneity in breast cancer assessed by microangiography and immunohistochemistry. Br J Surg 1996; 83: 702 (abstract).
17. Giatromanolaki A, Koukourakis MI, Theodossiou D, Barbatis K, O'Byrne K, Harris AL et al. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin Cancer Res 1997; 3: 2485-92.
18. Takahashi Y, Cleary KR, Mai M, Kitadai Y, Bucana CD, Ellis LM. Significance of vessel count and vascular endothelial growth factor and its receptor (KDR) in intestinal-type gastric cancer. Clin Cancer Res 1996; 2: 1679-84.
19. Fugioka S, Yushida K, Yanagisawa S, Kawakami M, Teruaki A, Yamazaki Y. Angiogenesis in pancreatic carcinoma-thymidine phosphylase expression in stromal cells and intrumoral microvessel density as independent predictors of overall and relapse-free survival. Cancer 2001; 92: 1788-97.
20. Folkman J. Angiogenesis in breast cancer. In: Bland KI and Copeland EM (eds). Molecular Biology of Breast Carcinogenesis and Metastasis. 1998: 586-603.
21. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, Mc Culloch P et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Europ J of Cancer 1996; 32A: 2474-84.
22. Ozaki H, Hiraoka T, Mizumoto R, Matsuno S, Matsumoto Y, Nakayama T et al. The prognostic significance of lymph node metastasis and intrapancreatic perineural invasion in pancreatic cancer after curative resection. Surg Today 1999; 29: 16-22.
23. Cameron JL, Crist DW, Sitzman JV. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991; 161: 120-4.
24. Yeo C, Abrams R, Grochow L, Sohn TA, Ord SE, Hruban RH et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single institution experience. Ann Surg 1997; 225: 621-33.
25. Neoptolemos JP, Stocken DD, Dunn JA et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-I Randomized controlled trial. Ann Surg 2001; 234: 758-68.